AAPM released a statement today expressing concern about Walmart’s new policy that limits initial opioid prescriptions for acute pain to a seven-day supply and 50 MME/day. The Academy appreciates the many members who have contacted us to share their personal concerns and experiences regarding the negative impact this policy has proven to have on patients. The AMA would also like to hear directly from clinicians who have experienced problems. Share your story with AMA.
Share this post
Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email
